Stifel Nicolaus Maintains Buy on Vertex Pharmaceuticals, Raises Price Target to $275

Stifel Nicolaus maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $243 to $275.

Benzinga · 01/31/2020 15:16

Stifel Nicolaus maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target from $243 to $275.